Assessment of acute coronary syndromes: focus on novel biomarkers.
Coronary artery disease (CAD) is the leading cause of mortality in Western Societies and several developing countries. Recent evidence suggests that most detrimental clinical manifestations of CAD, such as acute coronary syndromes (ACS), are the outcome of inflammatory processes that lead to plaque...
Päätekijät: | Tousoulis, D, Hatzis, G, Papageorgiou, N, Androulakis, E, Bouras, G, Giolis, A, Bakogiannis, C, Siasos, G, Latsios, G, Antoniades, C, Stefanadis, C |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2012
|
Samankaltaisia teoksia
-
From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand.
Tekijä: Tousoulis, D, et al.
Julkaistu: (2010) -
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
Tekijä: Kampoli, A, et al.
Julkaistu: (2012) -
The impact of statin administration in acute coronary syndromes.
Tekijä: Papageorgiou, N, et al.
Julkaistu: (2010) -
C-reactive protein and endothelial dysfunction: Gazing at the coronaries
Tekijä: Tousoulis, D, et al.
Julkaistu: (2011) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
Tekijä: Tousoulis, D, et al.
Julkaistu: (2011)